4-Cholesten 3-One

4-Cholesten 3-One

SCHEMBL55896

CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1L1 Q9UHC9 1/20 0.79
PTPN1 P18031 1/20 0.73
CYP17A1 P05093 4/20 0.70
MAPT P10636 2/20 0.70
KDM4E B2RXH2 1/20 0.70
SMN1; SMN2 Q16637 1/20 0.70
USP2 O75604 2/20 0.67
LMNA P02545 4/20 0.63
HSD17B10 Q99714 3/20 0.63
NR3C1 P04150 2/20 0.63
SHBG P04278 2/20 0.63
PGR P06401 2/20 0.63
SERPINA6 P08185 2/20 0.63
CYP3A4 P08684 2/20 0.63
AR P10275 2/20 0.63
CYP19A1 P11511 2/20 0.63
TSHR P16473 2/20 0.63
SNCA P37840 2/20 0.63
CACNA1C Q13936 2/20 0.63
CYP51A1 Q16850 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
4-Cholesten 3-One SCHEMBL25996870 1.00 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTKDM4E
4-Cholesten 3-One SCHEMBL1688732 1.00 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTKDM4E
4-Cholesten 3-One SCHEMBL10308280 1.00 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTKDM4E
4-Cholesten 3-One SCHEMBL20094570 1.00 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTKDM4E
4-Cholesten 3-One SCHEMBL24151936 1.00 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTKDM4E
4-Cholesten 3-One SCHEMBL23452819 1.00 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTKDM4E
4-Cholesten 3-One SCHEMBL19506686 1.00 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTKDM4E
4-Cholesten 3-One SCHEMBL2600424 1.00 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTKDM4E
4-Cholesten 3-One SCHEMBL21176042 1.00 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTKDM4E
4-Cholesten 3-One SCHEMBL601331 0.98 NPC1L1 (0.79) NPC1L1PTPN1CYP17A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4820 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4743437-A1 DIESTER LIPIDS, LIPID NANOPARTICLE CONTAINING DIESTER LIPIDS, AND FORMULATIONS THEREOF Providence Therapeutics Holdings Inc. (CA) 2026-05-20 EP claimed
WO-2026100273-A1 METHOD FOR PRODUCING USEFUL SUBSTANCE, CULTURE SOLUTION FOR CULTURING ALGAE, APPARATUS FOR PRODUCING USEFUL SUBSTANCE, AND ALGAE CONTAINING USEFUL SUBSTANCE NTT株式会社 2026-05-15 WO claimed
EP-4731258-A1 LIPID NANOPARTICLES CONTAINING DISULFIDE LIPIDS AND FORMULATIONS THEREOF Providence Therapeutics Holdings Inc. (CA) 2026-04-29 EP claimed
US-20260077000-A1 METABOLIC MODULATION OF INTRATUMORAL CHOLESTEROL WITH ENGINEERED BACTERIA FOR THE TREATMENT OF CANCERS UNIV HONG KONG BAPTIST UNIV (CN) 2026-03-19 US claimed
EP-4707402-A1 BIOELECTROCHEMICAL HYDROXYLATION OF SUBSTRATES USING FUNCTIONAL WATER-DEPENDENT ALKYL-HYDROXYLASE HYBRID ELECTRODES AND RESPECTIVE BIOFILM HYBRID ELECTRODES Albert-Ludwigs-Universität Freiburg Körperschaft des öffentlichen Rechts (DE) 2026-03-11 EP claimed
US-20260062716-A1 LIPID NANOPARTICLE (LNP) COMPOSITION OR FORMULATION FOR NUCLEIC ACID THERAPEUTICS POPVAX PRIVATE LTD (IN) 2026-03-05 US claimed
US-20250313860-A1 EXPRESSION OF EXOGENOUS PROTEINS IN DONOR PLATELETS TREATED WITH LIPID NANOPARTICLES THE UNIVERSITY OF BRITISH COLUMBIA (CA) 2025-10-09 US claimed
US-20250269035-A1 INHALABLE LIPID NANOPARTICLE, LIPID-CHARGED MOLECULE CONJUGATE, AND LIPID-ZWITTERIONIC MOLECULE CONJUGATE INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2025-08-28 US claimed
US-20250248939-A1 LIPID NANOPARTICLES, NUCLEIC ACIDS, AND METHODS OF USE CITY OF HOPE 2025-08-07 US claimed
EP-4591859-A1 LIPID NANOPARTICLE, PREPARATION METHOD THEREFOR, AND USE THEREOF INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2025-07-30 EP claimed
EP-0560983-A1 NOVEL CHOLESTEROL OXIDASE KYOWA HAKKO KOGYO CO., LTD. (JP) 1993-09-22 EP claimed
EP-0322081-B1 MICROBIOLOGICAL PREPARATION OF 9-ALPHA-HYDROXY-17-KETO STEROIDS ROUSSEL-UCLAF (FR) 1992-12-16 EP claimed
EP-0452112-A1 Cholesterol oxidase KYOWA HAKKO KOGYO CO., LTD. (JP) 1991-10-16 EP claimed
EP-0378395-A2 Method of measuring cholesterol, diagnosing vascular disease, and raising HDL cholesterol levels Maines, Robert Q. (US) 1990-07-18 EP claimed
EP-0322081-A1 Microbiological preparation of 9-alpha-hydroxy-17-keto steroids ROUSSEL-UCLAF (FR) 1989-06-28 EP claimed
US-4376733-A Preparation of oxacycloalkenones FRIMER ARYEH 1983-03-15 US claimed
EP-0011235-B1 9-ALPHA-HYDROXY-3-OXOPREGNA-4,17(20)-DIENE-20-CARBOXYLIC ACID AND ITS METHYL ESTER AND METHODS FOR THE MICROBIOLOGICAL PRODUCTION THEREOF MITSUBISHI KASEI CORPORATION (JP) 1982-06-23 EP claimed
US-4093517-A FROM MICROORGANISMS IN A YEAST EXTRACT, FERMENTATION EASTMAN KODAK COMPANY (US) 1978-06-06 US claimed
US-4052263-A Production of cholesterol esterase using Nocardia cholesterolicum EASTMAN KODAK COMPANY (US) 1977-10-04 US claimed
US-4035237-A CULTIVATION OF NOCARDIA IN A NUTRIENT MEDIUM CONTAINING CHOLESTEROL OR A DERIVATIVE EASTMAN KODAK COMPANY (US) 1977-07-12 US claimed